A single-blind, randomized, controlled trial shows zinc-L-carnosine improves oral mucositis in cancer patients, suggesting better quality of life.
These data confirm the clinical efficacy of Hepilor® in the treatment of oral mucositis in cancer patients. Together with an adequate oral hygiene, it reduced the severity of oral mucositis and its related symptoms, improving patients' quality of life.
No takes yet. Share an insight, caveat, or question.
Togni et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: